Anti-NKX3.1 (NT) Antibody (34013)
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Rabbit Immunogen Synthetic peptide corresponding to aa residues 21-37 (TPSKPLTSFLIQDILRD) of human NKX3.1 conjugated to KLH at the C- terminus. Product Concentration Lot Specific Formulation PBS, pH 7.4. State of Matter Liquid Product Preparation Purified by peptide immuno-affinity chromatography Storage and Handling This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze- thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Applications and Recommended Usage? Quality Tested by Leinco Immunoblotting : use at 1:1,000
Positive control: Human prostate tissue extracts. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Rabbit Polyclonal Antibody specific to NKX3.1 Antibody (NT) Background NKX3.1 is a homeobox gene which exhibits prostate- and testis-specific expression. Loss of NKX3.1 expression has been implicated in prostate development and tumorigenesis. NKX3.1 expression is dramatically down-regulated in testicular cancer of germ cell origin. Results suggest that NKX3.1 is essential for normal testis function and that its loss of expression is highly associated with the invasive phenotype of testicular germ cell tumors. Function Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells. {PubMed:19462257}. NCBI Gene Bank ID UniProt.org Research Area Cancer Research References & CitationsLind GE. et al. (2005) Mol Cancer. 4:8. Gelmann E.P. et al. (2003) Prostate 55:111-117. Technical ProtocolsCertificate of Analysis |
